カテゴリ： 世界, 医療/バイオ, QYResearch

ファビピラビル錠の世界市場2023年：ブランド薬、ジェネリック薬

■ 英語タイトル：Global Favipiravir Tablets Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8760）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8760
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：91
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥435,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥652,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ファビピラビル錠の世界市場2023年：ブランド薬、ジェネリック薬]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はファビピラビル錠のグローバル市場について調査・分析し、世界のファビピラビル錠市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（ブランド薬、ジェネリック薬）、用途別セグメント分析（インフルエンザウイルス、新型コロナウイルス感染症、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、ChemRar Group、Glenmark、Fujifilm、Dr. Reddy、R-Pharma、Cipla、Lupin、Sun Pharma、Hisun Pharmなどが含まれています。ファビピラビル錠のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ファビピラビル錠市場規模を算出する際に考慮しました。

・ファビピラビル錠市場の概要
- 製品の定義
- ファビピラビル錠の種類別セグメント
- 世界のファビピラビル錠市場規模：タイプ別分析（ブランド薬、ジェネリック薬）
- ファビピラビル錠の用途別セグメント
- 世界のファビピラビル錠市場規模：用途別分析（インフルエンザウイルス、新型コロナウイルス感染症、その他）
- 世界のファビピラビル錠市場規模予測（2018年-2029年）
- ファビピラビル錠の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ファビピラビル錠市場の競争状況およびトレンド

・ファビピラビル錠の地域別市場規模
- 北米のファビピラビル錠市場規模（2018年-2029年）
- 米国のファビピラビル錠市場規模（2018年-2029年）
- ヨーロッパのファビピラビル錠市場規模（2018年-2029年）
- アジア太平洋のファビピラビル錠市場規模（2018年-2029年）
- 中国のファビピラビル錠市場規模（2018年-2029年）
- 日本のファビピラビル錠市場規模（2018年-2029年）
- 韓国のファビピラビル錠市場規模（2018年-2029年）
- インドのファビピラビル錠市場規模（2018年-2029年）
- オーストラリアのファビピラビル錠市場規模（2018年-2029年）
- 中南米のファビピラビル錠市場規模（2018年-2029年）
- 中東・アフリカのファビピラビル錠市場規模（2018年-2029年）

・種類別セグメント：ブランド薬、ジェネリック薬
- 世界のファビピラビル錠のタイプ別販売量（2018年-2023年）
- 世界のファビピラビル錠のタイプ別売上（2018年-2023年）
- 世界のファビピラビル錠のタイプ別価格

・用途別セグメント：インフルエンザウイルス、新型コロナウイルス感染症、その他
- 世界のファビピラビル錠の用途別販売量（2018年-2023年）
- 世界のファビピラビル錠の用途別売上（2018年-2023年）
- 世界のファビピラビル錠の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
ChemRar Group、Glenmark、Fujifilm、Dr. Reddy、R-Pharma、Cipla、Lupin、Sun Pharma、Hisun Pharm

・産業チェーンと販売チャネルの分析
- ファビピラビル錠産業チェーン分析
- ファビピラビル錠の主要原材料
- ファビピラビル錠の販売チャネル
- ファビピラビル錠のディストリビューター
- ファビピラビル錠の主要顧客

・ファビピラビル錠市場ダイナミクス
- ファビピラビル錠の業界動向
- ファビピラビル錠市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Favipiravir Tablets market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Favipiravir Tablets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Favipiravir Tablets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Favipiravir Tablets include ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma, Cipla, Lupin, Sun Pharma and Hisun Pharm, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Favipiravir Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Favipiravir Tablets.
The Favipiravir Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Favipiravir Tablets market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Favipiravir Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla
Lupin
Sun Pharma
Hisun Pharm
Segment by Type
Brand Drug
Generic Drug
Segment by Application
Influenza Viruses
COVID-19
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Favipiravir Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Favipiravir Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Favipiravir Tablets Market Overview
1.1 Product Overview and Scope of Favipiravir Tablets
1.2 Favipiravir Tablets Segment by Type
1.2.1 Global Favipiravir Tablets Market Value Comparison by Type (2023-2029)
1.2.2 Brand Drug
1.2.3 Generic Drug
1.3 Favipiravir Tablets Segment by Application
1.3.1 Global Favipiravir Tablets Market Value by Application: (2023-2029)
1.3.2 Influenza Viruses
1.3.3 COVID-19
1.3.4 Others
1.4 Global Favipiravir Tablets Market Size Estimates and Forecasts
1.4.1 Global Favipiravir Tablets Revenue 2018-2029
1.4.2 Global Favipiravir Tablets Sales 2018-2029
1.4.3 Global Favipiravir Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Favipiravir Tablets Market Competition by Manufacturers
2.1 Global Favipiravir Tablets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Favipiravir Tablets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Favipiravir Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Favipiravir Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Favipiravir Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Favipiravir Tablets, Product Type & Application
2.7 Favipiravir Tablets Market Competitive Situation and Trends
2.7.1 Favipiravir Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Favipiravir Tablets Players Market Share by Revenue
2.7.3 Global Favipiravir Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Favipiravir Tablets Retrospective Market Scenario by Region
3.1 Global Favipiravir Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Favipiravir Tablets Global Favipiravir Tablets Sales by Region: 2018-2029
3.2.1 Global Favipiravir Tablets Sales by Region: 2018-2023
3.2.2 Global Favipiravir Tablets Sales by Region: 2024-2029
3.3 Global Favipiravir Tablets Global Favipiravir Tablets Revenue by Region: 2018-2029
3.3.1 Global Favipiravir Tablets Revenue by Region: 2018-2023
3.3.2 Global Favipiravir Tablets Revenue by Region: 2024-2029
3.4 North America Favipiravir Tablets Market Facts & Figures by Country
3.4.1 North America Favipiravir Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Favipiravir Tablets Sales by Country (2018-2029)
3.4.3 North America Favipiravir Tablets Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Favipiravir Tablets Market Facts & Figures by Country
3.5.1 Europe Favipiravir Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Favipiravir Tablets Sales by Country (2018-2029)
3.5.3 Europe Favipiravir Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Favipiravir Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Favipiravir Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Favipiravir Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Favipiravir Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Favipiravir Tablets Market Facts & Figures by Country
3.7.1 Latin America Favipiravir Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Favipiravir Tablets Sales by Country (2018-2029)
3.7.3 Latin America Favipiravir Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Favipiravir Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Favipiravir Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Favipiravir Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Favipiravir Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Favipiravir Tablets Sales by Type (2018-2029)
4.1.1 Global Favipiravir Tablets Sales by Type (2018-2023)
4.1.2 Global Favipiravir Tablets Sales by Type (2024-2029)
4.1.3 Global Favipiravir Tablets Sales Market Share by Type (2018-2029)
4.2 Global Favipiravir Tablets Revenue by Type (2018-2029)
4.2.1 Global Favipiravir Tablets Revenue by Type (2018-2023)
4.2.2 Global Favipiravir Tablets Revenue by Type (2024-2029)
4.2.3 Global Favipiravir Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Favipiravir Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Favipiravir Tablets Sales by Application (2018-2029)
5.1.1 Global Favipiravir Tablets Sales by Application (2018-2023)
5.1.2 Global Favipiravir Tablets Sales by Application (2024-2029)
5.1.3 Global Favipiravir Tablets Sales Market Share by Application (2018-2029)
5.2 Global Favipiravir Tablets Revenue by Application (2018-2029)
5.2.1 Global Favipiravir Tablets Revenue by Application (2018-2023)
5.2.2 Global Favipiravir Tablets Revenue by Application (2024-2029)
5.2.3 Global Favipiravir Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Favipiravir Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 ChemRar Group
6.1.1 ChemRar Group Corporation Information
6.1.2 ChemRar Group Description and Business Overview
6.1.3 ChemRar Group Favipiravir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 ChemRar Group Favipiravir Tablets Product Portfolio
6.1.5 ChemRar Group Recent Developments/Updates
6.2 Glenmark
6.2.1 Glenmark Corporation Information
6.2.2 Glenmark Description and Business Overview
6.2.3 Glenmark Favipiravir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Glenmark Favipiravir Tablets Product Portfolio
6.2.5 Glenmark Recent Developments/Updates
6.3 Fujifilm
6.3.1 Fujifilm Corporation Information
6.3.2 Fujifilm Description and Business Overview
6.3.3 Fujifilm Favipiravir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Fujifilm Favipiravir Tablets Product Portfolio
6.3.5 Fujifilm Recent Developments/Updates
6.4 Dr. Reddy
6.4.1 Dr. Reddy Corporation Information
6.4.2 Dr. Reddy Description and Business Overview
6.4.3 Dr. Reddy Favipiravir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Dr. Reddy Favipiravir Tablets Product Portfolio
6.4.5 Dr. Reddy Recent Developments/Updates
6.5 R-Pharma
6.5.1 R-Pharma Corporation Information
6.5.2 R-Pharma Description and Business Overview
6.5.3 R-Pharma Favipiravir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 R-Pharma Favipiravir Tablets Product Portfolio
6.5.5 R-Pharma Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Favipiravir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Cipla Favipiravir Tablets Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Lupin
6.6.1 Lupin Corporation Information
6.6.2 Lupin Description and Business Overview
6.6.3 Lupin Favipiravir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lupin Favipiravir Tablets Product Portfolio
6.7.5 Lupin Recent Developments/Updates
6.8 Sun Pharma
6.8.1 Sun Pharma Corporation Information
6.8.2 Sun Pharma Description and Business Overview
6.8.3 Sun Pharma Favipiravir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sun Pharma Favipiravir Tablets Product Portfolio
6.8.5 Sun Pharma Recent Developments/Updates
6.9 Hisun Pharm
6.9.1 Hisun Pharm Corporation Information
6.9.2 Hisun Pharm Description and Business Overview
6.9.3 Hisun Pharm Favipiravir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Hisun Pharm Favipiravir Tablets Product Portfolio
6.9.5 Hisun Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Favipiravir Tablets Industry Chain Analysis
7.2 Favipiravir Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Favipiravir Tablets Production Mode & Process
7.4 Favipiravir Tablets Sales and Marketing
7.4.1 Favipiravir Tablets Sales Channels
7.4.2 Favipiravir Tablets Distributors
7.5 Favipiravir Tablets Customers
8 Favipiravir Tablets Market Dynamics
8.1 Favipiravir Tablets Industry Trends
8.2 Favipiravir Tablets Market Drivers
8.3 Favipiravir Tablets Market Challenges
8.4 Favipiravir Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Favipiravir Tablets Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Favipiravir Tablets Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Favipiravir Tablets Market Competitive Situation by Manufacturers in 2022
Table 4. Global Favipiravir Tablets Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Favipiravir Tablets Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Favipiravir Tablets Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Favipiravir Tablets Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Favipiravir Tablets Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Favipiravir Tablets, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Favipiravir Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Favipiravir Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Favipiravir Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Favipiravir Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Favipiravir Tablets as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Favipiravir Tablets Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Favipiravir Tablets Sales by Region (2018-2023) & (K Units)
Table 18. Global Favipiravir Tablets Sales Market Share by Region (2018-2023)
Table 19. Global Favipiravir Tablets Sales by Region (2024-2029) & (K Units)
Table 20. Global Favipiravir Tablets Sales Market Share by Region (2024-2029)
Table 21. Global Favipiravir Tablets Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Favipiravir Tablets Revenue Market Share by Region (2018-2023)
Table 23. Global Favipiravir Tablets Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Favipiravir Tablets Revenue Market Share by Region (2024-2029)
Table 25. North America Favipiravir Tablets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Favipiravir Tablets Sales by Country (2018-2023) & (K Units)
Table 27. North America Favipiravir Tablets Sales by Country (2024-2029) & (K Units)
Table 28. North America Favipiravir Tablets Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Favipiravir Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Favipiravir Tablets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Favipiravir Tablets Sales by Country (2018-2023) & (K Units)
Table 32. Europe Favipiravir Tablets Sales by Country (2024-2029) & (K Units)
Table 33. Europe Favipiravir Tablets Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Favipiravir Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Favipiravir Tablets Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Favipiravir Tablets Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Favipiravir Tablets Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Favipiravir Tablets Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Favipiravir Tablets Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Favipiravir Tablets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Favipiravir Tablets Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Favipiravir Tablets Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Favipiravir Tablets Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Favipiravir Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Favipiravir Tablets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Favipiravir Tablets Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Favipiravir Tablets Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Favipiravir Tablets Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Favipiravir Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Favipiravir Tablets Sales (K Units) by Type (2018-2023)
Table 51. Global Favipiravir Tablets Sales (K Units) by Type (2024-2029)
Table 52. Global Favipiravir Tablets Sales Market Share by Type (2018-2023)
Table 53. Global Favipiravir Tablets Sales Market Share by Type (2024-2029)
Table 54. Global Favipiravir Tablets Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Favipiravir Tablets Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Favipiravir Tablets Revenue Market Share by Type (2018-2023)
Table 57. Global Favipiravir Tablets Revenue Market Share by Type (2024-2029)
Table 58. Global Favipiravir Tablets Price (US$/Unit) by Type (2018-2023)
Table 59. Global Favipiravir Tablets Price (US$/Unit) by Type (2024-2029)
Table 60. Global Favipiravir Tablets Sales (K Units) by Application (2018-2023)
Table 61. Global Favipiravir Tablets Sales (K Units) by Application (2024-2029)
Table 62. Global Favipiravir Tablets Sales Market Share by Application (2018-2023)
Table 63. Global Favipiravir Tablets Sales Market Share by Application (2024-2029)
Table 64. Global Favipiravir Tablets Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Favipiravir Tablets Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Favipiravir Tablets Revenue Market Share by Application (2018-2023)
Table 67. Global Favipiravir Tablets Revenue Market Share by Application (2024-2029)
Table 68. Global Favipiravir Tablets Price (US$/Unit) by Application (2018-2023)
Table 69. Global Favipiravir Tablets Price (US$/Unit) by Application (2024-2029)
Table 70. ChemRar Group Corporation Information
Table 71. ChemRar Group Description and Business Overview
Table 72. ChemRar Group Favipiravir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. ChemRar Group Favipiravir Tablets Product
Table 74. ChemRar Group Recent Developments/Updates
Table 75. Glenmark Corporation Information
Table 76. Glenmark Description and Business Overview
Table 77. Glenmark Favipiravir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Glenmark Favipiravir Tablets Product
Table 79. Glenmark Recent Developments/Updates
Table 80. Fujifilm Corporation Information
Table 81. Fujifilm Description and Business Overview
Table 82. Fujifilm Favipiravir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Fujifilm Favipiravir Tablets Product
Table 84. Fujifilm Recent Developments/Updates
Table 85. Dr. Reddy Corporation Information
Table 86. Dr. Reddy Description and Business Overview
Table 87. Dr. Reddy Favipiravir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Dr. Reddy Favipiravir Tablets Product
Table 89. Dr. Reddy Recent Developments/Updates
Table 90. R-Pharma Corporation Information
Table 91. R-Pharma Description and Business Overview
Table 92. R-Pharma Favipiravir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. R-Pharma Favipiravir Tablets Product
Table 94. R-Pharma Recent Developments/Updates
Table 95. Cipla Corporation Information
Table 96. Cipla Description and Business Overview
Table 97. Cipla Favipiravir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Cipla Favipiravir Tablets Product
Table 99. Cipla Recent Developments/Updates
Table 100. Lupin Corporation Information
Table 101. Lupin Description and Business Overview
Table 102. Lupin Favipiravir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Lupin Favipiravir Tablets Product
Table 104. Lupin Recent Developments/Updates
Table 105. Sun Pharma Corporation Information
Table 106. Sun Pharma Description and Business Overview
Table 107. Sun Pharma Favipiravir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Sun Pharma Favipiravir Tablets Product
Table 109. Sun Pharma Recent Developments/Updates
Table 110. Hisun Pharm Corporation Information
Table 111. Hisun Pharm Description and Business Overview
Table 112. Hisun Pharm Favipiravir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Hisun Pharm Favipiravir Tablets Product
Table 114. Hisun Pharm Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Favipiravir Tablets Distributors List
Table 118. Favipiravir Tablets Customers List
Table 119. Favipiravir Tablets Market Trends
Table 120. Favipiravir Tablets Market Drivers
Table 121. Favipiravir Tablets Market Challenges
Table 122. Favipiravir Tablets Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Favipiravir Tablets
Figure 2. Global Favipiravir Tablets Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Favipiravir Tablets Market Share by Type in 2022 & 2029
Figure 4. Brand Drug Product Picture
Figure 5. Generic Drug Product Picture
Figure 6. Global Favipiravir Tablets Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Favipiravir Tablets Market Share by Application in 2022 & 2029
Figure 8. Influenza Viruses
Figure 9. COVID-19
Figure 10. Others
Figure 11. Global Favipiravir Tablets Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Favipiravir Tablets Market Size (2018-2029) & (US$ Million)
Figure 13. Global Favipiravir Tablets Sales (2018-2029) & (K Units)
Figure 14. Global Favipiravir Tablets Average Price (US$/Unit) & (2018-2029)
Figure 15. Favipiravir Tablets Report Years Considered
Figure 16. Favipiravir Tablets Sales Share by Manufacturers in 2022
Figure 17. Global Favipiravir Tablets Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Favipiravir Tablets Players: Market Share by Revenue in 2022
Figure 19. Favipiravir Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Favipiravir Tablets Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Favipiravir Tablets Sales Market Share by Country (2018-2029)
Figure 22. North America Favipiravir Tablets Revenue Market Share by Country (2018-2029)
Figure 23. United States Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Favipiravir Tablets Sales Market Share by Country (2018-2029)
Figure 26. Europe Favipiravir Tablets Revenue Market Share by Country (2018-2029)
Figure 27. Germany Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Favipiravir Tablets Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Favipiravir Tablets Revenue Market Share by Region (2018-2029)
Figure 34. China Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Favipiravir Tablets Sales Market Share by Country (2018-2029)
Figure 44. Latin America Favipiravir Tablets Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Favipiravir Tablets Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Favipiravir Tablets Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Favipiravir Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Favipiravir Tablets by Type (2018-2029)
Figure 54. Global Revenue Market Share of Favipiravir Tablets by Type (2018-2029)
Figure 55. Global Favipiravir Tablets Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Favipiravir Tablets by Application (2018-2029)
Figure 57. Global Revenue Market Share of Favipiravir Tablets by Application (2018-2029)
Figure 58. Global Favipiravir Tablets Price (US$/Unit) by Application (2018-2029)
Figure 59. Favipiravir Tablets Value Chain
Figure 60. Favipiravir Tablets Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 炭酸リチウム医療用錠剤の世界市場2023年：徐放錠、普通錠
  • ドロスピレノン＆エチニルエストラジオール錠の世界市場インサイト・予測（～2028年）
  • フーファンイガンリン錠の世界市場2023年：フィルムコート錠、その他
  • メシル酸イマチニブ錠のグローバル市場展望 2023年-2029年：100 mg、400 mg
  • クロレラ錠の世界市場2023年：クロレラ・ブルガリス、クロレラ・ピレノイドサ
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8760 )"ファビピラビル錠の世界市場2023年：ブランド薬、ジェネリック薬" (英文：Global Favipiravir Tablets Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。